Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Novel copper-catalyzed route for thiotrifluoroacetamide intermediates ensures high purity and scalable manufacturing for global pharmaceutical supply chains and cost reduction.
Novel route for dexamethasone using tetraene-pregna-3,20-diketone reduces steps and cost for pharmaceutical intermediate manufacturing.
Novel telescoped synthesis reduces costs and simplifies purification for high-purity sulfachloropyridazine sodium production suitable for veterinary applications.
Patent CN108440365A enables cost-effective pyrrole synthesis using oxygen oxidant. Reduces environmental risk and enhances supply chain reliability for pharma intermediates.
Patent CN114524787B reveals oxidative coupling method. High selectivity, green solvent. Reliable supply for polymer manufacturing.
Patent CN104447557B reveals mild copper-catalyzed route for N-aryl heterocycles. Enables scalable manufacturing with simplified purification for global pharmaceutical supply chains.
Patent CN103467552A reveals a metal-free route for 8-cyclohexyl-2-fluoro-vidarabine. Enhanced purity and scalable manufacturing for anti-leukemia drug development.
Novel catalytic method for Antioxidant 168 ensures 99.5% purity and 97% yield. Reduces costs and enhances supply chain reliability for polymer manufacturers.
Novel synthesis of Roxadustat via Bischler-Napieralski cyclization offers high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN120484042B reveals a 5-step HE3286 synthesis route offering significant cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply chain reliability.
Novel 9,11-epoxy route reduces steps and cost for fluorometholone manufacturing. Reliable supplier for high-purity steroid intermediates.
Patent CN101805389A details a novel 3-step semi-synthetic route for Corosolic Acid from Ursolic Acid, offering >98% purity and significant cost reduction for pharmaceutical manufacturing.
Patent CN105523999B reveals a high-yield synthesis route for dabigatran etexilate intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112142617A details a novel oxidative carbonylation method for synthesizing alpha,beta-unsaturated alkynamides with high selectivity and recyclable catalysts.
Advanced synthesis of 5-oxo-tetrahydropyran-3-carboxylic ester via Pd-catalyzed carbonylation. Offers cost reduction in API manufacturing and scalable production.
Patent CN104761600B reveals a glucose-derived catalyst enabling efficient Aldol reactions. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101652350B reveals a cost-effective iodide-mediated dehalogenation route for high-purity 2-haloimidazoles, enhancing supply chain reliability.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Patent CN114230468A reveals a green SBA-15 catalytic route for nitrobenzaldehyde. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.